PolyNovo Limited (ASX: PNV), an Australian based medical company, has received approval to sell its NovoSorb BTM product throughout the European Union and UK/Ireland.
- NovoSorb BTM is a dermal scaffold for the regeneration of dermis when lost through extensive surgery or burn;
- The company’s shares were placed in a trading halt this morning before opening of the market.
At AEST 01:14PM, the stock was trading at $1.950 per share, up by 12.392% from its previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.